SARS-CoV-2 disease and children under treatment for cancer

Affiliations

Comment

Monica Terenziani et al. Pediatr Blood Cancer. 2020 Sep.

. 2020 Sep;67(9):e28346.

doi: 10.1002/pbc.28346. Epub 2020 May 6.

¹ Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Pediatric Oncology Unit, Milan, Italy.

No abstract available

Conflict of interest statement

The authors declare that there is no conflict of interest.

Managing COVID-19 in the oncology clinic and avoiding the distraction effect.
Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Cortiula F, et al. Ann Oncol. 2020 May;31(5):553-555. doi: 10.1016/j.annonc.2020.03.286. Epub 2020 Mar 19. Ann Oncol. 2020. PMID: 32201224 Free PMC article. No abstract available.

1. Liang W, Guan W, Chen R, et al. Cancer patients in SARS‐CoV‐2 infection: a nationwide analysis in China. Lancet Oncol. 2020;3:335‐337. - PMC - PubMed
1. D'Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl. 2020. 10.1002/lt.25756. [Epub ahead of print] - DOI - PubMed
1. Ludvigsson JF. Systematic review of COVID‐19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020. 10.1111/apa.15270. [Epub ahead of print] - DOI - PMC - PubMed
1. Lu X, Zhang L, Du H, et al. SARS‐CoV‐2 infection in children. N Engl J Med. 2020. 10.1056/NEJMc2005073. [Epub ahead of print] - DOI - PMC - PubMed
1. Soudani N, Caniza MA, Assaf‐Casals A, et al. Prevalence and characteristics of acute respiratory virus infections in pediatric cancer patients. J Med Virol. 2019;7:1191‐1201. - PMC - PubMed